Last reviewed · How we verify

oxytocin nasal spray

University of Electronic Science and Technology of China · FDA-approved active Small molecule

oxytocin nasal spray is a Neuropeptide Small molecule drug developed by University of Electronic Science and Technology of China. It is currently FDA-approved for Autism spectrum disorder (social communication deficits), Social anxiety disorder. Also known as: Pitocin, Syntocinon® Nasal Spray, Syntocinon, Oxytocin.

Oxytocin nasal spray delivers the neuropeptide oxytocin directly to the brain via intranasal administration to modulate social bonding, trust, and emotional processing.

Oxytocin nasal spray delivers the neuropeptide oxytocin directly to the brain via intranasal administration to modulate social bonding, trust, and emotional processing. Used for Autism spectrum disorder (social communication deficits), Social anxiety disorder.

At a glance

Generic nameoxytocin nasal spray
Also known asPitocin, Syntocinon® Nasal Spray, Syntocinon, Oxytocin, Syntocinon Intranasal Spray
SponsorUniversity of Electronic Science and Technology of China
Drug classNeuropeptide
TargetOxytocin receptor (OXTR)
ModalitySmall molecule
Therapeutic areaPsychiatry/Neurology
PhaseFDA-approved

Mechanism of action

Oxytocin is an endogenous neuropeptide that acts on oxytocin receptors in the brain to promote prosocial behaviors, emotional recognition, and social cognition. The intranasal formulation bypasses the blood-brain barrier to achieve central nervous system delivery. This mechanism has been explored for conditions involving social dysfunction and emotional processing deficits.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about oxytocin nasal spray

What is oxytocin nasal spray?

oxytocin nasal spray is a Neuropeptide drug developed by University of Electronic Science and Technology of China, indicated for Autism spectrum disorder (social communication deficits), Social anxiety disorder.

How does oxytocin nasal spray work?

Oxytocin nasal spray delivers the neuropeptide oxytocin directly to the brain via intranasal administration to modulate social bonding, trust, and emotional processing.

What is oxytocin nasal spray used for?

oxytocin nasal spray is indicated for Autism spectrum disorder (social communication deficits), Social anxiety disorder.

Who makes oxytocin nasal spray?

oxytocin nasal spray is developed and marketed by University of Electronic Science and Technology of China (see full University of Electronic Science and Technology of China pipeline at /company/university-of-electronic-science-and-technology-of-china).

Is oxytocin nasal spray also known as anything else?

oxytocin nasal spray is also known as Pitocin, Syntocinon® Nasal Spray, Syntocinon, Oxytocin, Syntocinon Intranasal Spray.

What drug class is oxytocin nasal spray in?

oxytocin nasal spray belongs to the Neuropeptide class. See all Neuropeptide drugs at /class/neuropeptide.

What development phase is oxytocin nasal spray in?

oxytocin nasal spray is FDA-approved (marketed).

What are the side effects of oxytocin nasal spray?

Common side effects of oxytocin nasal spray include Nasal irritation, Headache, Nausea, Transient increase in anxiety.

What does oxytocin nasal spray target?

oxytocin nasal spray targets Oxytocin receptor (OXTR) and is a Neuropeptide.

Related